Sumitomo Pharma Co Ltd
TSE:4506

Watchlist Manager
Sumitomo Pharma Co Ltd Logo
Sumitomo Pharma Co Ltd
TSE:4506
Watchlist
Price: 591 JPY -6.49% Market Closed
Market Cap: 234.8B JPY
Have any thoughts about
Sumitomo Pharma Co Ltd?
Write Note

Relative Value

The Relative Value of one Sumitomo Pharma Co Ltd stock under the Base Case scenario is 1 015.66 JPY. Compared to the current market price of 591 JPY, Sumitomo Pharma Co Ltd is Undervalued by 42%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
1 015.66 JPY
Undervaluation 42%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
60
vs Industry
82
Median 3Y
0.7
Median 5Y
0.8
Industry
2.6
Forward
0.7
vs History
vs Industry
Median 3Y
-0.7
Median 5Y
9.4
Industry
23
Forward
-23.1
vs History
vs Industry
26
Median 3Y
4.4
Median 5Y
5.7
Industry
17.8
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
2.3
Industry
25.4
vs History
7
vs Industry
59
Median 3Y
0.7
Median 5Y
0.9
Industry
2.2
vs History
68
vs Industry
75
Median 3Y
0.8
Median 5Y
0.9
Industry
2.8
Forward
0.8
vs History
46
vs Industry
78
Median 3Y
1.3
Median 5Y
1.4
Industry
5.4
vs History
vs Industry
5
Median 3Y
-0.8
Median 5Y
4.5
Industry
13.7
Forward
11.4
vs History
vs Industry
Median 3Y
-0.7
Median 5Y
6.2
Industry
17.2
Forward
-133.8
vs History
vs Industry
13
Median 3Y
4
Median 5Y
6
Industry
16.5
vs History
vs Industry
Median 3Y
-1
Median 5Y
6.4
Industry
19.3
vs History
65
vs Industry
80
Median 3Y
0.4
Median 5Y
0.4
Industry
2

Multiples Across Competitors

Competitors Multiples
Sumitomo Pharma Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Sumitomo Pharma Co Ltd
TSE:4506
234.8B JPY 0.7 -0.9 -1 -0.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
746.8B USD 18.3 89.2 48 53.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
365.6B USD 4.2 24.9 12 15.7
US
Merck & Co Inc
NYSE:MRK
249.1B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.5B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.8
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.4 168.8 253
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
JP
Sumitomo Pharma Co Ltd
TSE:4506
Average P/E: 33.1
Negative Multiple: -0.9
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
89.2
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
24.9
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.1
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.4
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top